Chopra H, Bibi S, Singh I, Hasan M, Khan M, Yousafi Q
Front Bioeng Biotechnol. 2022; 10:874742.
PMID: 35464722
PMC: 9019488.
DOI: 10.3389/fbioe.2022.874742.
Vandendriessche S, Cambier S, Proost P, Marques P
Front Cell Dev Biol. 2021; 9:624025.
PMID: 33644062
PMC: 7905230.
DOI: 10.3389/fcell.2021.624025.
Das A, Sinha M, Datta S, Abas M, Chaffee S, Sen C
Am J Pathol. 2015; 185(10):2596-606.
PMID: 26118749
PMC: 4607753.
DOI: 10.1016/j.ajpath.2015.06.001.
Kim S, Park S, Kim S, Bae D, Pyo J, Hong M
Mol Cell Biol. 2012; 32(14):2698-708.
PMID: 22566688
PMC: 3416206.
DOI: 10.1128/MCB.06743-11.
Desai N
AAPS J. 2012; 14(2):282-95.
PMID: 22407288
PMC: 3326161.
DOI: 10.1208/s12248-012-9339-4.
Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance.
Park S, Kim S, Jung M, Bae D, Kim I
Mol Cell Biol. 2008; 28(17):5288-98.
PMID: 18573870
PMC: 2519725.
DOI: 10.1128/MCB.01993-07.
Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment.
Rosse W
J Clin Invest. 1971; 50(4):734-43.
PMID: 16695957
PMC: 291987.
DOI: 10.1172/JCI106544.
Development of complement therapeutics for inhibition of immune-mediated red cell destruction.
Yazdanbakhsh K
Transfusion. 2005; 45(2 Suppl):122S-9S.
PMID: 16086799
PMC: 4797633.
DOI: 10.1111/j.1537-2995.2005.00526.x.
The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
Spitzer R, Stitzel A, Pauling V, Davis N, WEST C
J Exp Med. 1971; 134(3 Pt 1):656-80.
PMID: 15776568
PMC: 2139058.
DOI: 10.1084/jem.134.3.656.
Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells.
Hoffmann P, deCathelineau A, Ogden C, Leverrier Y, Bratton D, Daleke D
J Cell Biol. 2001; 155(4):649-59.
PMID: 11706053
PMC: 2198875.
DOI: 10.1083/jcb.200108080.
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.
Ogden C, deCathelineau A, Hoffmann P, Bratton D, Ghebrehiwet B, Fadok V
J Exp Med. 2001; 194(6):781-95.
PMID: 11560994
PMC: 2195958.
DOI: 10.1084/jem.194.6.781.
Serum heat-labile opsonins in systemic lupus erythematosus.
Jasin H, Orozco J, ZIFF M
J Clin Invest. 1974; 53(2):343-53.
PMID: 11344546
PMC: 301475.
DOI: 10.1172/JCI107566.
CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.
Oldenborg P, Gresham H, Lindberg F
J Exp Med. 2001; 193(7):855-62.
PMID: 11283158
PMC: 2193364.
DOI: 10.1084/jem.193.7.855.
Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus.
Spika J, Verbrugh H, Verhoef J
Infect Immun. 1981; 34(2):455-60.
PMID: 7309234
PMC: 350888.
DOI: 10.1128/iai.34.2.455-460.1981.
Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.
Fearon D, Kaneko I, Thomson G
J Exp Med. 1981; 153(6):1615-28.
PMID: 7252422
PMC: 2186197.
DOI: 10.1084/jem.153.6.1615.
Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
Medof M, PRINCE G, Oger J
Clin Exp Immunol. 1982; 48(3):715-25.
PMID: 7116690
PMC: 1536626.
A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
Brown E, Hosea S, HAMMER C, Burch C, Frank M
J Clin Invest. 1982; 69(1):85-98.
PMID: 7054244
PMC: 371171.
DOI: 10.1172/jci110444.
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.
Edwards M, Nicholson-Weller A, Baker C, Kasper D
J Exp Med. 1980; 151(5):1275-87.
PMID: 6989947
PMC: 2185859.
DOI: 10.1084/jem.151.5.1275.
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
Fearon D
J Exp Med. 1980; 152(1):20-30.
PMID: 6967510
PMC: 2185895.
DOI: 10.1084/jem.152.1.20.
Evidence for presence of an internal thiolester bond in third component of human complement.
Tack B, Harrison R, Janatova J, Thomas M, Prahl J
Proc Natl Acad Sci U S A. 1980; 77(10):5764-8.
PMID: 6934510
PMC: 350151.
DOI: 10.1073/pnas.77.10.5764.
